This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Centene (CNC) Announces Solid Financial Guidance for 2021
by Zacks Equity Research
Centene (CNC) provides an impressive 2021 guidance for key metrics owing to its strong inorganic growth story and a healthy revenue stream.
Centene (CNC) to Purchase Specialty Pharmacy PANTHERx Rare
by Zacks Equity Research
Centene (CNC) to buy specialty pharmacy PANTHERx Rare to penetrate the specialty drug market and cater to patients with complex situations.
3 Health Insurers That Crushed S&P YTD, Set to Rise Further
by Srijita Guha
We zero in on three health insurers that outperform the S&P Index YTD on the back of solid fundamentals. All these stocks hold prospects to continue the rally going forward.
Acadia Healthcare (ACHC) Forms JV to Boost Service in Detroit Area
by Zacks Equity Research
Acadia Healthcare (ACHC) partners with Henry Ford Health System for offering improved mental health services in Detroit and neighboring counties.
Ensign Group (ENSG) Bolsters Presence in Texas With Buyout
by Zacks Equity Research
Ensign Group (ENSG) acquires a skilled nursing facility in Texas, which further adds stimulus to the company's acquisition spree.
Is Molina Healthcare (MOH) Outperforming Other Medical Stocks This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Is Molina Healthcare (MOH) a Worthy Pick for Value Investors?
by Zacks Equity Research
Let's see if Molina Healthcare (MOH) stock is a good choice for value-oriented investors right now from multiple angles.
Improving Patient Volumes Aid Select Medical's (SEM) Prospects
by Zacks Equity Research
Recovery in patient volumes owing to relaxation of government-imposed constraints is gradually restoring the patient admissions, thereby reinstating Select Medical (SEM) on the growth path.
Why You Should Add Molina Healthcare (MOH) to Your Portfolio
by Zacks Equity Research
Banking on strategic measures and growing revenues, Molina Healthcare (MOH) holds enough potential to reap benefits for investors.
Encompass Health (EHC) Continues to Bolster Presence in Ohio
by Zacks Equity Research
Encompass Health (EHC) continues to expand in Ohio via inauguration of the inpatient rehabilitation hospital in order to offer improved health services in the state.
Humana (HUM) to Offer MA Plans in Massachusetts for First Time
by Zacks Equity Research
Humana's (HUM) Medicare Advantage plans to make a debut in Massachusetts for fortifying the company's foothold in the state.
Centene (CNC) Marketplace Product Undergoes Technology Upgrade
by Zacks Equity Research
Centene's (CNC) Marketplace product - Ambetter undertakes technology improvements for benefiting members and new enrollees.
Is Molina Healthcare (MOH) Stock Outpacing Its Medical Peers This Year?
by Zacks Equity Research
Is (MOH) Outperforming Other Medical Stocks This Year?
Humana (HUM) Inks Deal to Better Serve Members in Kansas Area
by Zacks Equity Research
Humana (HUM) partners Prime Healthcare to mete out better healthcare facilities to members residing in the Kansas region.
Humana (HUM), Northwell Tie Up for Better Health Outcome
by Zacks Equity Research
Humana (HUM) partners with Northwell to provide improved healthcare services in the New York metropolitan region.
Cigna (CI) Rides on a Diversified Business, Capital Position
by Zacks Equity Research
Cigna's (CI) prolific business profile and a solid balance sheet position poise it well for long-term growth.
Molina Healthcare's (MOH) Q3 Earnings Beat, Increase Y/Y
by Zacks Equity Research
Molina Healthcare's (MOH) third-quarter results reflect higher revenues and membership.
Molina (MOH) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 53.43% and 3.68%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Molina (MOH) Q3 Earnings Expected to Decline
by Zacks Equity Research
Molina (MOH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Humana (HUM) Expands in Tennessee to Boost Medicare Business
by Zacks Equity Research
Humana (HUM) expands Medicare Advantage in 31 rural counties of the Knoxville, Memphis, Nashville regions as well as drives benefits for veterans.
Humana Adds Retail Pharmacies to Medicare Part D Network
by Zacks Equity Research
Humana (HUM) adds Kroger Health and its chain of pharmacies to its preferred stand-alone Medicare Part D pharmacy network, to be effective 2021.
Humana's (HUM) MA Members Gain From Better Health Outcomes
by Zacks Equity Research
Humana's (HUM) individual Medicare Advantage patients enjoy value-based heathcare at reasonable costs.
Humana, FMCNA Expand Services for Better Health Outcomes
by Zacks Equity Research
Humana (HUM) expands agreement with Fresenius Medical Care North America to provide better healthcare for Humana Medicare Advantage and commercial members with CKD and ESRD.
Humana Ties Up to Offer Better Healthcare in Colorado Springs
by Zacks Equity Research
Humana (HUM) partners Centura Health in Colorado Springs to dispense high-quality in-network medical care for Humana Medicare Advantage members.
Humana Ties Up to Provide Improved Healthcare in Chicago
by Zacks Equity Research
Humana (HUM) partners Rush Health to offer in-network medical care in the Chicago region for Humana Medicare Advantage members.